Literature DB >> 9865344

Positive effects of tacrolimus in a case of CIDP.

J Ahlmén1, O Andersen, G Hallgren, B Peilot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9865344     DOI： 10.1016/s0041-1345(98)01389-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

Review 1.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Inna Kleyman; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

2.  An update on the management of chronic inflammatory demyelinating polyneuropathy.

Authors:  Kenneth C Gorson
Journal:  Ther Adv Neurol Disord       Date:  2012-11       Impact factor: 6.570

Review 3.  Chronic inflammatory demyelinating polyneuropathies: current treatment strategies.

Authors:  Thomas B Toothaker; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

4.  Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin.

Authors:  M Odaka; M Tatsumoto; K Susuki; K Hirata; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

5.  Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins.

Authors:  Meng-Ge Yang; Li Xu; Suqiong Ji; Huajie Gao; Qing Zhang; Bitao Bu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-06-16       Impact factor: 2.989

Review 6.  Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Krista Kuitwaard; Pieter A van Doorn
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

7.  Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Eduardo Adonias De Sousa; Thomas H Brannagan
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

8.  Late onset tacrolimus-induced life-threatening polyneuropathy in a kidney transplant recipient patient.

Authors:  Delphine Renard; Thierry Gauthier; Jean-Pierre Venetz; Thierry Buclin; Thierry Kuntzer
Journal:  Clin Kidney J       Date:  2012-08

9.  Tacrolimus treatment for relapsing-remitting chronic inflammatory demyelinating polyradiculoneuropathy: Two case reports.

Authors:  Wen-Jia Zhu; Yu-Wei Da; Hai Chen; Min Xu; Yan Lu; Li Di; Jian-Ying Duo
Journal:  World J Clin Cases       Date:  2022-02-16       Impact factor: 1.337
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.